semaglutide gastrointestinal obstruction class action in michigan Subocclusive ileus following off-label high-dose semaglutide use in: Endocrinology, Diabetes & Metabolism Case Reports Volume 2025 Issue 4 (2025)-mvanhaasteren.nl Ozempic® Lawsuit | July 2026
Description
These steps are critical to achieving reliable and reproducible experimental data
All-inclusive, bilingual.
Results Across all BMI categories, semaglutide pretreatment was associated with lower pregnancy and live birth rates compared with matched controls
Up to 64% of GLP-1 patients discontinue therapy
Ozempic carries potentially serious side effects
